News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Drugs & Diseases > Endocrinology

      Growth Hormone Deficiency in Adults

      Updated: Jun 17, 2022
      • Author: Mohsen S Eledrisi, MD, FACP, FACE; Chief Editor: George T Griffing, MD  more...
      • Print
      Overview

      Background

      The somatotroph cells of the anterior pituitary gland produce growth hormone (GH), which is stimulated by GH-releasing hormone (GHRH) and inhibited by somatostatin, both of which are produced by the hypothalamus.

      Adult GH deficiency can be a transition from childhood-onset GH deficiency, or it can be acquired during adulthood. The majority of cases are caused by pituitary tumors or by their treatment with surgery, radiation therapy, or both. [1] Traumatic brain injury is another important cause. [1, 2, 3, 4, 5]

      GH deficiency in adults is associated with multiple metabolic changes such as abnormal lipid metabolism (increased total cholesterol and low-density lipoprotein cholesterol [LDL-C], increased triglycerides, and reduced high-density lipoprotein cholesterol [HDL-C]), increased subcutaneous and visceral fat, decreased muscle mass, decreased bone density, and features of the metabolic syndrome. [6, 7, 8] Patients usually present with reduced physical performance, impaired psychological well-being, low exercise performance, and reduced quality of life. [1]

      The goals of GH therapy in adults are to improve conditioning, strength, body composition, and quality of life, as well as reduce the burden of potential associated medical conditions such as cardiovascular disease and decreased bone mineral density.

      Patients should be educated about the technique of subcutaneous injection of GH.

      For patient education resources, see Thyroid and Metabolism Center as well as Growth Hormone Deficiency, Growth Hormone Deficiency Medications, and Growth Hormone Deficiency FAQs.

      Next:

      Etiology

      Causes of growth hormone (GH) deficiency can be divided into three categories: acquired, congenital, and idiopathic. [9]

      Acquired conditions of GH deficiency include tumors of the pituitary gland or the hypothalamus and metastatic disease; surgery or radiation therapy of the pituitary or hypothalamus; infiltrative diseases such as sarcoidosis, tuberculosis, histiocytosis X, hemochromatosis, and lymphocytic hypophysitis; infarction of the pituitary or hypothalamus (which can be spontaneous, or result from Sheehan syndrome or ischemic stroke); subarachnoid hemorrhage; infections of the central nervous system; and head trauma (during the acute stage of the injury and during the rehabilitation stage). [2, 3, 4, 5, 10, 11] ​ [12]

      Congenital conditions are caused by genetic abnormalities or structural brain defects. Genetic abnormalities include transcription factor defects (PIT-1, PROP-1, LHX3/4, HESX-1, PITX-2), GH-releasing hormone (GHRH) receptor gene defects, GH gene defects, and GH-receptor or post-receptor defects. Structural defects include agenesis of the corpus callosum, septo-optic dysplasia, empty sella syndrome, encephalocele, hydrocephalus, and arachnoid cyst. GH deficiency can occur in association with midline facial defects such as single central incisor, cleft lip, and cleft palate.

      In rare cases, no clear etiology can be determined for GH deficiency. [9]

      Previous
      Next:

      Epidemiology

      An estimated 6,000 adults are diagnosed with growth hormone (GH) deficiency every year in the United States. [2] Adult GH deficiency has been estimated to affect 1 in 100,000 people annually, whereas its incidence is approximately 2 cases per 100,000 population when childhood-onset GH deficiency patients are considered. [13, 14] About 15-20% of the cases represent the transition of childhood GH deficiency into adulthood. [13] The incidence rate is higher in males with childhood-onset GH deficiency and in people older than 45 years in the adult GH deficiency group. [13]

      The age of presentation of acquired GH deficiency in adults often coincides with the discovery of pituitary tumors, usually between the fourth and fifth decades of life.

      Previous
      Clinical Presentation
       
       
      Media Gallery
      of 0
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.